Well if that's the case, I just have to tell you Jay Leno's joke he did about 2 weeks ago ... (went something like ...)
"Did you know that more than half of Americans will have diabetes or be prediabetic by 2020? That's the good news. The bad news is: the other half will have diabetes tomorrow."
I went online to check Jay's joke and it's true. Diabetes is going to be a 3.35 trillion dollar expense to the US healthcare system if things don't change by 2020. That's only 6 years away, which means a company like DRIO and others are going to be addressing a serious issue in the US and the world.
Here's one link I found:
Sentiment: Strong Buy
What does Warren say? When others run, buy. When others buy, sell. Call me dum! ;) But I'm buying more at these prices. I have to think where this company will be long term with a great product. I'm taking losses with my existing shares. Bummer. But at least my cost basis is going down and potential overall profit up! ;-) Once they get their Dario product out there and generate some revenue, their stock price should go up, and up, and up ....
Yes, Virginia, there is a Santa Claus. And Santa is called DRIO.
I wouldn't worry too much about the price going down. With low volume stocks, the price can fluctuate a lot. I think its based more on a few sellers that want out NOW versus overall sediment of where this company is going. DRIO launched their app today, which is good, and their price drops? If you want to get your spirits up over DRIO, check out the YouTube videos with users who describe why they like the Dario product. I think DRIO has a great product for a huge, worldwide markeplace.
Last Friday, Jay Leno started his show with (something like):
"They're developing a printer that can print out a heart, but it's not covered by Obamacare. The printers are cheap, but the darn printer cartridges are too expensive."
Organovo wasn't named in the joke.
Today's article focuses on liver assays. But ONVO has patent-pending bio printers which can be used in many other applications not menitoned in his article. Printing skin grafts for burn patients. Printing small arteries. I think the list goes on and on as do the possiblities on a global scale. Call me crazy, but I expect this stock to hit $25 in 2014.
Make that 15 European countries, not companies. They do have agreements already in place with companies to sell their product in Europe too.
Gotta love this company. Over 4M cash on hand. Product will start selling First Qtr 2014. Global product for a 50B market in 2011 expected to be 98B market in 2018. Filed for patents. Has CE Approval to sell to 15 European companies, plus New Zealand and Australia. I just picked up mores shares at $2 when $10M worth of investors paid $2.50/share with $5 warrants. Zacks expects this to be $10 to $12/share company end of 2014. More people seem to be learning more about this company too. If I have my facts straight, this is all good ...
Plus Australia and New Zealand in addition to 15 countries in Europe.
Also liked the total diabetes market in 2011 was quoted as being 50.8 Billion and estimated to be 98.4 Billion in 2018 in 5 years. And Dario can be used to test other conditions/markets besides diabetes too.
Even without the patent, if you're first to market with an iPhone/Android phone diabetes tester, you'll usually end up being the number one device ... and in this case, worldwide!
I think the May 2013 private placement was at $2.50/share with $5 warrants. Can't seem to locate the share price, but the warrant price is from: "The 2,000,000 Warrants issued in connection with the May 2013 Private Placement are exercisable for shares of our common stock at an initial exercise price equal to $5.00 per share." So at $2.25 price today, that's a deal even if the price were to go down further.
Sentiment: Strong Buy
I bought more shares today at $2.35. I'm a bit overloaded on DRIO shares so I might sell once the price goes back up or maybe not. I think DRIO needs to show revenue and that may take longer than some are willing to wait for, so they sell/dump their shares in hopes of achieving greater gains elsewhere. It doesn't take many sellers or buyers to lower or raise the share price right now. As for any bad news as to why DRIO won't become a $10/share stock, I haven't heard any. ;-)
I watched the Shark Tank video. Their device would allow users to bypass pricking themselves to run a test and instead simply blow on their device to do a measurement. That's nice! I'd rather blow than be pricking myself thoughout the day. That said, this is a huge market and no one device is going to dominate the field. For example, I would think that older people might not be able to blow the minimum amount of air for their device to work.
As for patents and as a patent holder, I would think DRIO should be able to obtain their patents on Dario and the other company will get their patents for their device. The devices are different and don't overlap in my view. They represent two separate solutions both using a smartphone. But it will make it much more difficult for anyone coming after these two companies to enter into this market with similar solutions.
I think the fact that all 5 sharks bought into the proposal just indicates the potential DRIO has.
I looked up what a "CE Mark" means since the stock didn't go up as I had expected. The CE Mark seems to be more like a UL approval versus an FDA approval. From my view, they just want to make sure the device won't shock you. The CE Mark also seemed to be more of a self regulatory evaluation too. But it still is a major milestone and does allow DRIO to sell their Dario product to 35 countries. Even though I'm down overall on this stock, I bought another 2,000 shares today at 2.49. Call me crazy, but this still seems like a sweatheart price that will pay off in the future.
I'm really surprised. I was expecting a big jump after the CE Mark. Why isn't there a big jump?
Yesterday, DRIO couldn't sell their product to 32 European countries, and today with the CE Mark, they can! That's a significant achievement in my view. And, DRIO has signed agreements to start selling their products using established distributors in U.K., Italy, and Belgium already. And with the CE Mark approval, they're going to accelerate getting FDA approval for the U.S. marketplace.
I don't care that the price is what it is today. DRIO's future looks great!!!!!!!!!!
Late August/Early September was expected. But if getting a CE Mark is anything like getting FDA approval, LabStyle can't dictate when approval will take place. So long as approval does come, I'll be happy.